Zhi‐Cheng Jing

17.8k total citations · 9 hit papers
221 papers, 10.6k citations indexed

About

Zhi‐Cheng Jing is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Zhi‐Cheng Jing has authored 221 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Pulmonary and Respiratory Medicine, 111 papers in Cardiology and Cardiovascular Medicine and 25 papers in Genetics. Recurrent topics in Zhi‐Cheng Jing's work include Pulmonary Hypertension Research and Treatments (145 papers), Cardiovascular Issues in Pregnancy (40 papers) and Cardiovascular Function and Risk Factors (26 papers). Zhi‐Cheng Jing is often cited by papers focused on Pulmonary Hypertension Research and Treatments (145 papers), Cardiovascular Issues in Pregnancy (40 papers) and Cardiovascular Function and Risk Factors (26 papers). Zhi‐Cheng Jing collaborates with scholars based in China, United States and United Kingdom. Zhi‐Cheng Jing's co-authors include Rogério Souza, Lewis J. Rubin, Nazzareno Galiè, Marc Humbert, David Langleben, Richard N. Channick, Hossein Ardeschir Ghofrani, Gérald Simonneau, Marion Delcroix and Ekkehard Grünig and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Zhi‐Cheng Jing

202 papers receiving 10.4k citations

Hit Papers

Updated Clinical Classifi... 2009 2026 2014 2020 2009 2013 2013 2016 2018 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Updated Clinical Classification of Pulmonary Hypertension
    2009 1.5k citations Maurice Beghetti, Zhi‐Cheng Jing et al. profile →
  2. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
    2013 948 citations Tomás Pulido, Nazzareno Galiè et al. profile →
  3. Riociguat for the Treatment of Pulmonary Arterial Hypertension
    2013 944 citations Hossein Ardeschir Ghofrani, Nazzareno Galiè et al. profile →
  4. A global view of pulmonary hypertension
    2016 591 citations Marius M. Hoeper, Marc Humbert et al. The Lancet Respiratory Medicine profile →
  5. Risk stratification and medical therapy of pulmonary arterial hypertension
    2018 521 citations Nazzareno Galiè, Ekkehard Grünig et al. European Respiratory Journal profile →
  6. Updated Treatment Algorithm of Pulmonary Arterial Hypertension
    2013 489 citations Nazzareno Galiè, Zhi‐Cheng Jing et al. profile →
  7. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
    2010 470 citations Marc Humbert, Zhi‐Cheng Jing et al. European Respiratory Journal profile →
  8. Pulmonary hypertension
    2024 132 citations Marc Humbert, Zhi‐Cheng Jing et al. profile →
  9. Treatment algorithm for pulmonary arterial hypertension
    2024 50 citations Zhi‐Cheng Jing et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhi‐Cheng Jing China 39 8.6k 5.8k 1.6k 1.3k 1.1k 221 10.6k
Ekkehard Grünig Germany 50 9.4k 1.1× 6.7k 1.2× 1.3k 0.8× 1.1k 0.9× 789 0.7× 253 11.5k
Rogério Souza Brazil 39 11.8k 1.4× 6.8k 1.2× 2.3k 1.4× 1.1k 0.8× 1.6k 1.5× 180 13.5k
Ivan M. Robbins United States 42 10.9k 1.3× 7.0k 1.2× 2.2k 1.4× 892 0.7× 1.4k 1.3× 106 12.2k
Raymond L. Benza United States 48 8.8k 1.0× 7.1k 1.2× 1.8k 1.2× 1.3k 1.0× 2.3k 2.1× 316 12.2k
Seán Gaine Ireland 38 6.8k 0.8× 4.0k 0.7× 1.2k 0.8× 1.0k 0.8× 1.0k 0.9× 143 8.2k
Laurent Savale France 52 6.6k 0.8× 3.4k 0.6× 1.5k 1.0× 798 0.6× 1.3k 1.2× 251 8.3k
Mardi Gomberg‐Maitland United States 45 7.1k 0.8× 5.2k 0.9× 1.1k 0.7× 772 0.6× 951 0.9× 148 8.5k
Joanna Pepke‐Żaba United Kingdom 44 7.9k 0.9× 4.9k 0.8× 1.6k 1.0× 623 0.5× 829 0.8× 131 9.1k
Xavier Jaïs France 62 11.4k 1.3× 6.8k 1.2× 2.6k 1.7× 659 0.5× 1.7k 1.6× 261 12.7k
Adam Torbicki Poland 50 9.7k 1.1× 10.6k 1.8× 1.7k 1.1× 619 0.5× 1.7k 1.6× 263 15.3k

Countries citing papers authored by Zhi‐Cheng Jing

Since Specialization
Citations

This map shows the geographic impact of Zhi‐Cheng Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Cheng Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Cheng Jing more than expected).

Fields of papers citing papers by Zhi‐Cheng Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Cheng Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Cheng Jing. The network helps show where Zhi‐Cheng Jing may publish in the future.

Co-authorship network of co-authors of Zhi‐Cheng Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Cheng Jing. A scholar is included among the top collaborators of Zhi‐Cheng Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Cheng Jing. Zhi‐Cheng Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prandoni, Paolo, Meg Fluharty, Sebastian Schellong, et al.. (2025). Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry. European Journal of Internal Medicine. 144. 106492–106492.
2.
Hua, Chen, Lihong Wang, Yunxiang Wang, et al.. (2025). Microwave Effects on the Flavor and Storage Quality of “Nongke Nuo 336” Sweet Corn. Journal of Future Foods.
3.
Wang, Xin, Xin Wang, Jing Wang, et al.. (2025). Deep Brain Stimulation in Parkinson's Disease Patients Over 75 Years of Age: A Single‐Institution Retrospective Analysis. CNS Neuroscience & Therapeutics. 31(5). e70397–e70397.
4.
Ufnal, Marcin, Marcus Millegård, Marco Guazzi, et al.. (2025). Relaxin Mimetic in Pulmonary Hypertension Associated with Left Heart Disease: Design and Rationale of Re-PHIRE. ESC Heart Failure. 12(3). 1956–1964. 1 indexed citations
5.
Qiu, Jiayong, Chao Liu, Yuejiao Ma, et al.. (2025). Pulmonary arterial hypertension: a long-standing and nonnegligible burden over three decades. Science Bulletin. 70(11). 1766–1769. 1 indexed citations
6.
Zuo, Jinhua, Zhi‐Cheng Jing, Yunxiang Wang, et al.. (2025). Comprehensive analysis of DNA methylome and transcriptome reveals the epigenetic regulation of nitric oxide treatment in delaying apricot fruit senescence. The Plant Journal. 123(4). e70387–e70387.
7.
Wang, Jia, Chao Liu, Hui‐Fang Wang, et al.. (2024). Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension. European Journal of Pharmacology. 970. 176492–176492. 3 indexed citations
8.
Zhou, Guangyuan, Yunpeng Wei, Ting Zhang, et al.. (2024). Identification of Noncoding Functional Regulatory Variants of STIM1 Gene in Idiopathic Pulmonary Arterial Hypertension. Hypertension. 81(9). 1895–1909. 1 indexed citations
9.
Wu, Xinhua, Yangyang He, Zhangrong Chen, et al.. (2023). Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotype. Nature Communications. 14(1). 1820–1820. 17 indexed citations
10.
Yang, Ming, et al.. (2023). Prognostic Value of Preoperative Assessment of Left Ventricular Function in Patients Undergoing Percutaneous Coronary Intervention. Reviews in Cardiovascular Medicine. 24(3). 80–80. 3 indexed citations
11.
Wei, Yunpeng, Xiaoyuan Liu, Lu Wang, et al.. (2022). Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility. Hypertension. 79(7). 1348–1360. 8 indexed citations
12.
Zhang, Hongda, Liting Wang, Alexander Rothman, et al.. (2017). Prognostic Significance of Reduced Blood Pressure Response to Exercise in Pediatric Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 196(11). 1478–1481. 1 indexed citations
13.
Hoeper, Marius M., Marc Humbert, Rogério Souza, et al.. (2016). A global view of pulmonary hypertension. The Lancet Respiratory Medicine. 4(4). 306–322. 591 indexed citations breakdown →
14.
Wang, Lan, Sen Jiang, Jingyun Shi, et al.. (2016). Clinical characteristics of pulmonary hypertension in bronchiectasis. Frontiers of Medicine. 10(3). 336–344. 8 indexed citations
15.
Jing, Zhi‐Cheng, Keyur Parikh, Tomás Pulido, et al.. (2013). Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension. Circulation. 127(5). 624–633. 242 indexed citations
16.
Galiè, Nazzareno, Friedrich Grimminger, Ekkehard Grünig, et al.. (2013). Correlation of improvements in hemodynamics and exercise capacity in patients with PAH: Results from the phase III PATENT-1 study. European Respiratory Journal. 42(Suppl 57). 1784–1784. 5 indexed citations
17.
Wu, Wenhui, Lu Yang, Fu-Hua Peng, et al.. (2012). Lower Socioeconomic Status Is Associated with Worse Outcomes in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 187(3). 303–310. 47 indexed citations
18.
Jing, Zhi‐Cheng, Zaixin Yu, Jieyan Shen, et al.. (2011). Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study. American Journal of Respiratory and Critical Care Medicine. 183(12). 1723–1729. 138 indexed citations
19.
Jing, Zhi‐Cheng, et al.. (2009). Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension. European Respiratory Journal. 33(6). 1354–1360. 69 indexed citations
20.
Jiang, Xin, Zhi-Yan Han, Xi‐Qi Xu, et al.. (2008). Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension. Chinese Medical Journal. 121(24). 2497–2503. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ekkehard Grünig Breakdown of academic impact, for papers by Rogério Souza Breakdown of academic impact, for papers by Ivan M. Robbins Breakdown of academic impact, for papers by Raymond L. Benza Breakdown of academic impact, for papers by Seán Gaine Breakdown of academic impact, for papers by Laurent Savale Breakdown of academic impact, for papers by Mardi Gomberg‐Maitland Breakdown of academic impact, for papers by Joanna Pepke‐Żaba Breakdown of academic impact, for papers by Xavier Jaïs Breakdown of academic impact, for papers by Adam Torbicki
Rankless by CCL
2026